Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Sexually Transmitted Infections (STI): later-stage trial registry

2 of 2 indexed Sexually Transmitted Infections (STI) trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Sexually Transmitted Infections (STI): 2 US clinical trials tracked, 2 recruiting.

Sexually Transmitted Infections (STI) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Emory University, running 1 of these trials.

Enrollment posture brief

Registry condition sexually-transmitted-infections-sti

OPEN 2 | RECR 100% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Sexually Transmitted Inf (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Sexually Transmitted Infections (STI)

Sexually Transmitted Infections (STI) lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sexually Transmitted Infections (STI) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sexually Transmitted Infections (STI) is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Sexually Transmitted Infections (STI) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Mobile Enhanced Prevention Support (MEPS) Behavioral
1 trials
Doxycycline monohydrate 200 mg Drug
1 trials
Control Other
1 trials
Observation Other
1 trials

US sites by state

Facility locations filed on Sexually Transmitted Infections (STI) trials. A trial with sites in several states counts in each.

Georgia 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sexually Transmitted Infections (STI) page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Sexually Transmitted Infections (STI) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Emory University sponsors the most Sexually Transmitted Infections (STI) trials on record, review their full trial history before evaluating a specific study. See Emory University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sexually Transmitted Infections (STI) condition card totals 2 registered trials; most-linked intervention Mobile Enhanced Prevention Support (MEPS); top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.